p53 gene mutations and p53 protein expression in human soft tissue sarcomas

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 4, 1997, Pages 395-399

  Yoo, Jinyoung ^a,b   Lee, Hun Kyung ^a   Kang, Chang Suk ^a   Park, Won Sang ^a   Lee, Jung Yong ^a   Shim, Sang Ln ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 17P; CLINICAL ARTICLE; EXON; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TUMOR SUPPRESSOR GENE;

CELL NUCLEUS; GENES, P53; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030948143     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70:523-526.
2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in thep53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res' 1994;54:4855-4878.
3. Levine A), Momand ), Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453-456.
4. Hall PA, Ray A, Lemoine NR, et al. p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet. 1991;338:513.
5. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-1354.
6. Gréer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am J Clin Pathol. 1991;95:117-124.
7. Barker S), Fearon ER, Nigro JM, et al. Chromosomal 17 deletions and p53 gene mutations in colorectal carcinoma. Science. 1989;244:217-221.
8. Andreassen A, Oyjord T, Hovig E, et al. p53 abnormalities in different subtypes of human sarcomas. Cancer Res. 1993;53:468-471.
9. Leach FS, Tokino T, Meltzer P, et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 1993;52:2231-2234.
10. Dobashi Y, Sakamoto A, Sugimura H, et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. J Surg Pathol. 1993;17: 375-381.
11. Cross-Bellard M, Oudet P, Chambon P. Isolation of high molecular DNA from mammalian cells, EurJ Biochem. 1973;36:32-38.
12. Buchmann VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP. A variation in the structure of the protein-coding region of the human p53 gene. Gene. 1988;70:245-252.
13. Saiki RK. Amplification of genomic DNA. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Applications. San Diego, Calif: Academic Press; 1989:13-20.
14. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissue. In: Innis MA, Gelfand DH, Sninsky J), White T), eds. PCR Protocols: A Guide to Methods and Applications. San Diego, Calif: Academic Press; 1989:153-158.
15. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sei USA. 1977;74:5463-5467.
16. Iggo R, Gatter K, Bartek ), Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Oncogene. 1990;335:675-679.
17. Campo E, de la Calle-Martin O, Miguel R. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer. 1991;51:4436-4442.
18. Cattoretti G, Rike F, Andreola S, D'Amato L, Delia D. p53 expression in breast cancer. Int] Cancer. 1988;41:178-183.
19. Wright PA, Lemoine NR, Goretzki PE, et al. Mutations of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumors. Oncogene. 1991;6:1693-1697.
20. Bartek ), Bartkova B, Staskova Z. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991;6:1699-1703.
21. Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletcher COM. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology. 1993;22:45-50.
22. VVadayama B, Toguchida I, Yamaguchi T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas, fir/ Cancer. 1993;68: 1134-1139.
23. Kawai A, Noguchi M, Beppu Y, et al. Nuclear immunoreaction of p53 protein in soft tissue sarcomas: a possible prognostic factor. Cancer. 1994;73: 2499-2505.
24. Morkve O, Laerum OD. Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas. Cytometry. 1991;12:438.
25. Hollstein M, Sidransky D, Vogelstein B, Harris CG p53 mutations in human cancers. Science. 1991;253:49-53.
26. Stratton MR, Moss S, Warren W, et al. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. 1990;5:1297-1301.
27. Mulligan LM, Matlashewski C], Scrable HJ, Cavenee WK. Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sei USA. 1990;84:7716-7719.
28. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 1992;52:6194-6199.
29. Oda H, Nakatsuru Y, Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res. 1995;55:658-662.
30. Caron de Fromentel C, Soussi T. TP 53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 1992;4:1 -15.
31. Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC. From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res. 1991;51:3617-3620.
32. Hollstein M, Marion M), Lehman T, et al. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis. 1994;5:1-3.
33. Koeberl DD, Bottema CDK, Ketterling RP, et al. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human genome. Am J Hum Genet. 1990;47:202-217.
34. Liu FS, Kohler MF, Marks JR. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet Gynecol. 1994;83:118-124.